SENHWA BIOSCIENCES, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.7 TWD | +0.24% |
|
+0.24% | -18.07% |
Chart calendar Senhwa Biosciences, Inc.
dc.4ek4HCdFdYnw7rHsdRxTZA6-9LhYDluChjk37ZYjPto.0KBeeFMfR92-2eaoKnMlHF7asIwIXgPG5HxBu8ZweL-3jAlVSAYY2MLZ_A~558475757fe2186a075783cccf1b0a88
Upcoming events on Senhwa Biosciences, Inc.
Past events on Senhwa Biosciences, Inc.
| 13/05/2024 | Q1 2025 Earnings Release |
| 05/04/2024 | American Association for Cancer Research Meeting |
| 02/04/2024 02:44 pm | March 2024 Sales and Revenue Release |
| 14/03/2024 01:40 pm | Q4 2023 Earnings Release |
| 04/03/2024 11:44 am | February 2024 Sales and Revenue Release |
| 01/02/2024 12:18 pm | January 2024 Sales and Revenue Release |
| 02/10/2023 | September 2023 Sales and Revenue Release |
| 05/09/2023 | August 2023 Sales and Revenue Release |
| 10/08/2023 12:39 pm | Q2 2023 Earnings Release |
| 02/08/2023 | July 2023 Sales and Revenue Release |
| 03/07/2023 | June 2023 Sales and Revenue Release |
| 30/06/2023 07:30 am | Annual General Meeting |
| 06/06/2023 | May 2023 Sales and Revenue Release |
| 05/05/2023 | April 2023 Sales and Revenue Release |
| 30/03/2023 | Q4 2022 Earnings Release |
| 11/11/2022 07:05 am | Q3 2022 Earnings Release |
| 27/03/2022 | American Academy of Dermatology Meeting |
| 20/01/2022 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium |
| 18/01/2021 04:00 am | American Society of Clinical Oncology Virtual Gastrointestinal Cancers Symposium - Abstract ID: 312 |
| 26/02/2018 | FY 2017 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 |
|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 0,30 0,00 - | 0,62 0,00 - | 0,55 1,00 -45% |
|
EBITDA Million TWD | Released Forecast Spread | -386 -414 6.85% | -352 -342 -2.97% | -340 -347 1.99% |
|
EBIT Million TWD | Released Forecast Spread | -394 -416 5.34% | -359 -343 -4.74% | -346 -352 1.61% |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 0,00 0,00 - | -354 -340 -4.23% | -328 -335 1.99% |
|
Net income Million TWD | Released Forecast Spread | 0,00 0,00 - | -355 -340 -4.38% | -329 -335 1.71% |
|
EPS TWD | Released Forecast Spread | 0,00 0,00 - | -4,49 -3,80 -18.16% | -3,67 -3,73 1.61% |
| Announcement Date | 19/03/20 | 25/03/21 | 11/03/22 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 |
|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 0,10 0,00 - | 0,25 845 -99.97% | 0,25 0,00 - |
|
EBIT Million TWD | Released Forecast Spread | -83,2 -89,0 6.57% | -78,6 681 -111.54% | -99,0 -86,0 -15.09% |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -81,6 -88,0 7.24% | -77,6 682 -111.39% | -97,6 -85,0 -14.82% |
|
Net income Million TWD | Released Forecast Spread | -82,5 -88,0 6.21% | -77,6 682 -111.39% | -97,6 -85,0 -14.82% |
|
EPS TWD | Released Forecast Spread | -0,92 -0,98 6.12% | -0,87 7,60 -111.45% | -1,09 -0,95 -14.74% |
| Announcement Date | 11/03/22 | 12/05/22 | 11/08/22 |
More events
Past sector events for Senhwa Biosciences, Inc.
| Today | BIOCON LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 05:30 pm | IMMUNOME, INC.: Q1 2024 Earnings Release |
| 14/05/2024 04:30 pm | IMMATICS N.V.: Q1 2024 Earnings Release |
| 14/05/2024 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
| 14/05/2024 10:30 am | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
| 14/05/2024 | ABL BIO INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6492 Stock
- Calendar Senhwa Biosciences, Inc.
